Clinical Trial

A Phase 1 Study of FIT-CD19-CAR-T Cells in R/R B-ALL

Name: A Phase 1 Study of FIT-CD19-CAR-T Cells in R/R B-ALL — clinical trial record (NCT07066397)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a Phase 1 study to evaluate FIT-CD19-CAR-T (ARM011) safety and tolerability, anti-tumor activity, cellular kinetics, immunogenicity, and exploratory biomarkers.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-07-04.

Status change: Not Yet Recruiting → Recruiting 2025-07-20

Trial Details

NCT Number	NCT07066397
Lead Sponsor	TriArm Therapeutics (Taiwan) Limited
Conditions	Acute Lymphoblastic Leukemia
Enrollment	12 participants
Start Date	2025-07-15
Primary Completion	2028-04-01 (estimated)
Study Completion	2041-04-01 (estimated)
Updated on ClinicalTrials.gov	2025-07-23